Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study.

Also, patients from the ERA group had higher ANA positivity (94% vs 68%; P = 0.075), ANA titer [1280 (1000; 2560) vs 320 (0; 5120); P = 0.077]; lower C3 [0.57 (0.4; 0.8) g/L vs 0.85 (0.7; 1.1) g/L; P = 0.059]; and C4 fractions of complements [0.10 (0.06; 0.14) g/L vs 0.19 (0.10; 0.24) g/L; P = 0.075] with borderline significance.

also in 7,017 other papers